Because uracil nucleotides are important signaling molecules that activate G-protein-coupled membrane receptors of the P2Y family33, we hypothesized that the release of UTP and UDP by cancer cells is a determinant factor in CDA-dependent resistance to anti-PD-1 therapy. The gene discussed is PDCD1; the disease is cancer.